Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Share-based Compensation (2021 - 2025)

Historic Share-based Compensation for P3 Health Partners (PIII) over the last 5 years, with Q3 2025 value amounting to $1.2 million.

  • P3 Health Partners' Share-based Compensation fell 3815.12% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 2292.99%. This contributed to the annual value of $5.8 million for FY2024, which is 379.66% down from last year.
  • According to the latest figures from Q3 2025, P3 Health Partners' Share-based Compensation is $1.2 million, which was down 3815.12% from $1.5 million recorded in Q2 2025.
  • P3 Health Partners' Share-based Compensation's 5-year high stood at $11.7 million during Q1 2022, with a 5-year trough of $355093.0 in Q3 2021.
  • Its 5-year average for Share-based Compensation is $2.1 million, with a median of $1.6 million in 2024.
  • Per our database at Business Quant, P3 Health Partners' Share-based Compensation surged by 244302.25% in 2022 and then tumbled by 9165.74% in 2023.
  • P3 Health Partners' Share-based Compensation (Quarter) stood at $2.3 million in 2021, then fell by 5.54% to $2.2 million in 2022, then decreased by 21.57% to $1.7 million in 2023, then plummeted by 58.08% to $721000.0 in 2024, then surged by 67.96% to $1.2 million in 2025.
  • Its Share-based Compensation stands at $1.2 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.8 million for Q1 2025.